Clinical Effectiveness of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Adult Obsessive-Compulsive Disorder (OCD) Treatment: A Systematic Review.
Cureus April 2023 Asila A Ferguson, Aujala Irfan Khan, Baraa Abuzainah et al.
Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder that affects approximately 2% of the human population. Traditional treatment of OCD includes selective serotonin reuptake inhibitor (SSRI) or serotonin reuptake inhibitor (SRI) treatment along with cognitive behavioral therapy (CBT). Nearly 25%-30% of OCD patients do not respond to SSRIs. Glutamatergic agents are currently being...
DOI: 10.7759/cureus.37833 (opens in new tab)
Full text (opens in new tab)
Esketamine
Amantadine
Ketamine infusion
Memantine
+2